Ceruloplasmin in neurodegenerative diseases

Area of Science:

• Neurobiology
• Biochemistry
• Genetics

Background:

• Abnormalities in ceruloplasmin (Cp) synthesis are linked to neurodegenerative diseases.
• Low serum Cp levels are a marker for Wilson's disease, while its complete absence characterizes aceruloplasminemia.
• Distinct mechanisms, including copper and iron accumulation, underlie Cp-associated neurodegeneration.

Purpose of the Study:

• To review ceruloplasmin (Cp) gene expression, structure, and function.
• To discuss the role of Cp in iron metabolism and its implications in neurodegeneration.
• To explore the molecular mechanisms of Cp-related neuropathology and potential therapeutic targets.

Main Methods:

• Literature review of ceruloplasmin (Cp) synthesis, function, and neuropathology.
• Analysis of molecular events in Wilson's disease and aceruloplasminemia.
• Discussion of Cp's roles in iron metabolism, antioxidant defense, and neuronal maintenance.

Main Results:

• Cp abnormalities are associated with distinct neurodegenerative conditions, Wilson's disease (copper accumulation) and aceruloplasminemia (iron accumulation).
• Cp's ferroxidase activity and its role in iron homeostasis are critical for preventing neurotoxicity.
• The precise functions of Cp in the central nervous system, including antioxidant roles, require further elucidation.

Conclusions:

• Understanding ceruloplasmin's (Cp) function in the central nervous system is crucial for neurodegenerative disease research.
• Further investigation into Cp's ferroxidase versus antioxidant roles may reveal treatment strategies for conditions like Alzheimer's and Parkinson's diseases.
• Elucidating the mechanisms of neuronal injury in Cp-related disorders is essential for developing effective therapies.